A Study to Investigate the Efficacy and Safety of Baxdrostat in Participants With Uncontrolled Hypertension on Two or More Medications Including Participants With Resistant Hypertension

Clinical trial NCT06034743 · COMPLETED

Trial details

NCT number: NCT06034743
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Uncontrolled Hypertension Resistant Hypertension

Start date: 2023-11-22
Primary completion: 2025-05-21
Enrollment: 796

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.